Fentanyl-related compounds and derivatives: current status and future prospects for pharmaceutical applications
RS Vardanyan, VJ Hruby - Future medicinal chemistry, 2014 - Taylor & Francis
Fentanyl and its analogs have been mainstays for the treatment of severe to moderate pain
for many years. In this review, we outline the structural and corresponding synthetic …
for many years. In this review, we outline the structural and corresponding synthetic …
Molecular docking reveals a novel binding site model for fentanyl at the μ-opioid receptor
G Subramanian, MG Paterlini… - Journal of medicinal …, 2000 - ACS Publications
The ligand binding modes of a series of fentanyl derivatives are examined using a
combination of conformational analysis and molecular docking to the μ-opioid receptor …
combination of conformational analysis and molecular docking to the μ-opioid receptor …
DARK classics in chemical neuroscience: fentanyl
SM Burns, CW Cunningham… - ACS chemical …, 2018 - ACS Publications
Fentanyl rose to prominence as an alternative analgesic to morphine nearly 50 years ago;
today, fentanyl has re-emerged as a dangerous recreational substance. The increased …
today, fentanyl has re-emerged as a dangerous recreational substance. The increased …
Synthesis and pharmacological studies of new hybrid derivatives of fentanyl active at the μ-opioid receptor and I2–imidazoline binding sites
C Dardonville, C Fernandez-Fernandez… - Bioorganic & medicinal …, 2006 - Elsevier
Two series of fentanyl-derived hybrid molecules bearing potent I2–imidazoline binding site
(IBS) ligands (ie, guanidine and BU224 moieties) linked with an aliphatic (m= 2, 3, 4, 6, 7, 8 …
(IBS) ligands (ie, guanidine and BU224 moieties) linked with an aliphatic (m= 2, 3, 4, 6, 7, 8 …
Fentanyl analogs: structure-activity-relationship study
S Vuckovic, M Prostran, M Ivanovic… - Current medicinal …, 2009 - ingentaconnect.com
Fentanyl is the prototype of the 4-anilidopiperidine class of synthetic opioid analgesics. This
study was aimed to review the structure-activity-relationship (SAR) of fentanyl analogs …
study was aimed to review the structure-activity-relationship (SAR) of fentanyl analogs …
Affinity, potency, efficacy, selectivity, and molecular modeling of substituted fentanyls at opioid receptors
AJ Eshleman, S Nagarajan, KM Wolfrum… - Biochemical …, 2020 - Elsevier
Substituted fentanyls are abused and cause rapid fatal overdose. As their pharmacology is
not well characterized, we examined in vitro pharmacology and structure–activity …
not well characterized, we examined in vitro pharmacology and structure–activity …
Synthesis, opioid receptor binding, and biological activities of naltrexone-derived pyrido-and pyrimidomorphinans
S Ananthan, HS Kezar, RL Carter… - Journal of medicinal …, 1999 - ACS Publications
A series of pyrido-and pyrimidomorphinans (6a− h and 7a− g) were synthesized from
naltrexone and evaluated for binding and biological activity at the opioid receptors. The …
naltrexone and evaluated for binding and biological activity at the opioid receptors. The …
An efficient, optimized synthesis of fentanyl and related analogs
CA Valdez, RN Leif, BP Mayer - PLoS One, 2014 - journals.plos.org
The alternate and optimized syntheses of the parent opioid fentanyl and its analogs are
described. The routes presented exhibit high-yielding transformations leading to these …
described. The routes presented exhibit high-yielding transformations leading to these …
Charting, navigating, and populating natural product chemical space for drug discovery
H Lachance, S Wetzel, K Kumar… - Journal of medicinal …, 2012 - ACS Publications
STRONGHOLDS FOR DRUG DISCOVERY Historically, natural products (NPs) have played
a key role in the development of chemotherapy, 1, 2 and to this very day numerous marketed …
a key role in the development of chemotherapy, 1, 2 and to this very day numerous marketed …
Novel approaches, drug candidates, and targets in pain drug discovery
Because of the problems associated with opioids, drug discovery efforts have been
employed to develop opioids with reduced side effects using approaches such as biased …
employed to develop opioids with reduced side effects using approaches such as biased …